UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance ...

The cell and gene therapies in rare disorders market is expected to grow at a significantly high rate during the forecast period (2025–2034) and main ...

Lung transplant recipients are highly vulnerable to infections, with Pseudomonas aeruginosa being a leading cause of bacterial pneumonia. Researchers have found in a new study that infection ...

This valuable study reports on the critical role of ANKRD5 (ANKEF1) in sperm motility and male fertility. However, the supporting data remain incomplete. This work will be of interest to biomedical ...

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...

A Comprehensive OverviewThe next-gen biomanufacturing market refers to the rapidly evolving sector where cutting-edge technologies are utilized to produce biologics, vaccines, and therapeutic proteins ...

Cerus Corporation (Nasdaq: CERS) today announced financial results for its full year and fourth quarter ended December 31, 2024. Recent highlights inc ...

According to multiple media reports on Thursday, Pfizer Inc. (NYSE:PFE) has terminated the global development and commercialization of its hemophilia B gene therapy, Beqvez. In April 2024, the FDA ...

Explore the evolution of vaccine technology from Jenner to mRNA, highlighting India's role in COVID-19 vaccine development.

MB310 has been developed as an oral capsule, dosed once daily, containing a defined consortium of eight live gut commensal ...

A groundbreaking gene therapy has restored sight in four young children born with severe blindness due to a rare genetic ...